ARAVIVE, INC Net Debt/EBITDA

Net Debt/EBITDA of ARAV for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.

Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending September 30, 2023 was 0.7 (a -43.55% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA decreased by -72.18%
  • Annual Net Debt/EBITDA for 2022 was 0.71 (a -46.96% decrease from previous year)
  • Annual Net Debt/EBITDA for 2021 was 1.34 (a -40.45% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was 2.25 (a -12.99% decrease from previous year)
Visit stockrow.com/ARAV for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of ARAVIVE, INC

Most recent Net Debt/EBITDAof ARAV including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of ARAVIVE, INC

ARAVIVE, INC Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.7 1.24 1.83 – –
2022 2.53 1.42 2.17 4.06 0.71
2021 3.95 5.35 9.47 9.07 1.34
2020 5.47 4.44 10.88 5.02 2.25
2019 10.9 4.96 9.83 7.77 2.58
2018 0.95 10.09 6.48 8.07 1.56
2017 8.64 2.28 3.74 5.3 0.9
2016 8.96 5.86 6.18 6.69 2.09
2015 9.02 9.68 11.04 10.36 2.21
2014 10.73 12.92 22.72 27.05 3.71
2013 2.26 0.0 0.0 0.0 0.69
2012 0.0 – – – 0.03

Business Profile of ARAVIVE, INC

Sector: Healthcare
Industry: Biotechnology
© stockrow.com